课题基金 / 基金详情

Immune responses to Norovirus after natural infection in Vietnamese children and

Immune responses to Norovirus after natural infection in Vietnamese children and
越南儿童和儿童自然感染后对诺如病毒的免疫反应
批准号:
8463872
负责人:
Xi Jiang
金额:
$4.89万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-25 至 2014-01-31

项目摘要

项目成果

Xi Jiang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This FIRCA-BB application intends to having a capacity development of a LMIC laboratory (Nguyen Van Trang, co-PI) at the National Institute of Hygiene and Epidemiology (NIHE) in Vietnam on norovirus (NV) research through collaboration with a well established NV research laboratory at the Cincinnati Children's Hospital Medical Center (CCHMC, Jiang, PI) in Cincinnati, Ohio. We will perform field surveillance of NV associated gastroenteritis in Vietnamese children focusing on three currently urgent topics on the virus/host interaction, immunology and evolution of NVs. We will determine the correlation of histo-blood group antigen (HBGA) status with susceptibility to NVs in children hospitalized with acute gastroenteritis; access immune responses to NVs following natural infection of children in clinical and community settings; and study the role of host herd immunity in NV evolution by genetic and antigenic characterization of GII.4 variants in the Vietnamese children. To improve the research capacity of the LMIC laboratory, we will particularly focus on the improvement of the surveillance network, training of laboratory personnel, and transferring or adapting of new technology, including developing new ones based on needs of the LMIC laboratory. Our goal is to have the LMIC laboratory becoming a national reference laboratory and Dr. Trang the national leader in the NV and rotavirus researches in Vietnam.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevalence of P[6] and P[11] rotaviruses in developing countries
Human monoclonal antibodies against norovirus.
Immune responses to Norovirus after natural infection in Vietnamese children and
Novel vaccine against Norovirus
海外基金